KRUS
Kura Sushi USA, Inc.
KRUS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCID
Lucid Group, Inc.
LCID has a slight edge over KRUS overall, supported by stronger fundamentals and lower modeled downside.
KRUS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Healthy |
KRUS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
KRUS PE Valuation
KRUS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 285x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
KRUS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect KRUS to return to profit, with revenue growing. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
KRUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.38 | -$0.22 |
| Q2 2026 | -$0.18 | +$0.63 |
| Q1 2026 | -$0.16 | +$0.75 |
| Q4 2025 | -$0.33 | +$0.36 |
| Q3 2025 | -$0.16 | +$0.63 |
| Q2 2025 | -$0.81 | -$0.78 |
| Q1 2025 | -$0.91 | -606% |
| Q4 2024 | -$0.69 | -506% |
KRUS is still losing money, but far less than before: $0.38 per share over the past year, against $0.91 at its worst in early 2025.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over KRUS on earnings, with more consistent year-over-year improvement.
KRUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $88.9M | +12% |
| Q2 2026 | $85.9M | +16% |
| Q1 2026 | $80M | +23% |
| Q4 2025 | $73.5M | +14% |
| Q3 2025 | $79.4M | +20% |
| Q2 2025 | $74M | +17% |
| Q1 2025 | $64.9M | +13% |
| Q4 2024 | $64.5M | +25% |
KRUS's revenue has grown year over year for 22 quarters in a row: $89M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.7% | -2.6 points |
| Q2 2026 | -0.1% | +0.2 points |
| Q1 2026 | -2.8% | +4.3 points |
| Q4 2025 | -5% | -2.7 points |
| Q3 2025 | 1.8% | +11 points |
| Q2 2025 | -0.2% | +1.6 points |
| Q1 2025 | -7.1% | -4.1 points |
| Q4 2024 | -2.3% | +3.2 points |
KRUS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over KRUS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
KRUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$244K | -$165K |
| Q2 2026 | -$3.7M | +$3.2M |
| Q1 2026 | -$7.9M | -$576K |
| Q4 2025 | -$13.3M | -$6.1M |
| Q3 2025 | -$79K | +$9.5M |
| Q2 2025 | -$6.9M | -$4.5M |
| Q1 2025 | -$7.3M | +$2.4M |
| Q4 2024 | -$7.2M | -$226K |
KRUS has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
KRUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -227K shares |
| 1 year | +1.8% | +216K shares |
| 3 years | +14% | +1.5M shares |
KRUS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
KRUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.6x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.4x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | -5.1x | Net Cash |
| Q2 2025 | -35.0x | Net Cash |
| Q4 2024 | -48.1x | Net Cash |
| Q3 2024 | -188.8x | Net Cash |
KRUS has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KRUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.5 | Neutral |
| Stochastic | 9.0 | Oversold |
KRUS's weekly RSI is 34 (neutral) and its Stochastic is 9 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
KRUS PE vs Consumer Cyclical Sector
| Metric | KRUS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
KRUS has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
KRUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.9 | 24% below |
| 20 week MA | $42.1 | 37% below |
| 50 week MA | $52.8 | 50% below |
| 100 week MA | $61.1 | 57% below |
| 200 week MA | $71.1 | 63% below |
KRUS is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
KRUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $18.9 | -30% |
| 2021 | $18.9 | $78.0 | +312% |
| 2022 | $78.0 | $51.1 | -35% |
| 2023 | $51.1 | $76.0 | +49% |
| 2024 | $76.0 | $90.2 | +19% |
| 2025 | $90.2 | $56.4 | -37% |
| 2026 YTD | $56.4 | $26.5 | -53% |
KRUS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.